Cargando…
Type 1 diabetes mellitus and its oral tolerance therapy
As a T cell-mediated autoimmune disease, type 1 diabetes mellitus (T1DM) is marked by insulin defect resulting from the destruction of pancreatic β-cells. The understanding of various aspects of T1DM, such as its epidemiology, pathobiology, pathogenesis, clinical manifestations, and complications, h...
Autores principales: | Mao, Rui-Feng, Chen, Ying-Ying, Zhang, Ji, Chang, Xin, Wang, Ye-Fu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Baishideng Publishing Group Inc
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7582116/ https://www.ncbi.nlm.nih.gov/pubmed/33133388 http://dx.doi.org/10.4239/wjd.v11.i10.400 |
Ejemplares similares
-
Oral tolerance therapy in type 1 diabetes mellitus
por: Mao, Rui-Feng, et al.
Publicado: (2021) -
Impaired secretion of glucagon-like peptide 1 during oral glucose tolerance test in patients with newly diagnosed type 2 diabetes mellitus
por: Wang, Xiao-Li, et al.
Publicado: (2016) -
The study of cognitive function in children with type 1 diabetes mellitus
por: Jia, NI, et al.
Publicado: (2013) -
Oral microbiota in children with type 1 diabetes mellitus
por: Pachoński, Marek, et al.
Publicado: (2021) -
Application of the Oral Minimal Model to Korean Subjects with Normal Glucose Tolerance and Type 2 Diabetes Mellitus
por: Lim, Min Hyuk, et al.
Publicado: (2016)